Literature DB >> 28221860

The Head Start Effect: Will Acute and Delayed Postoperative Mortality Lead to Improved Survival with Stereotactic Body Radiation Therapy for Operable Stage I Non-Small-Cell Lung Cancer?

Chad G Rusthoven1, David A Palma1, Suresh Senan1, Brian D Kavanagh1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28221860     DOI： 10.1200/JCO.2016.72.0003

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

1.  Surgery vs. SBRT in retrospective analyses: confounding by operability is the elephant in the room.

Authors:  William A Stokes; Chad G Rusthoven
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

2.  Stage III N2 non-small cell lung cancer treatment: decision-making among surgeons and radiation oncologists.

Authors:  Markus Glatzer; Pawel Leskow; Francesca Caparrotti; Olgun Elicin; Markus Furrer; Franco Gambazzi; André Dutly; Hans Gelpke; Matthias Guckenberger; Jürg Heuberger; Rolf Inderbitzi; Stefano Cafarotti; Wolfram Karenovics; Peter Kestenholz; Gregor Jan Kocher; Peter Kraxner; Thorsten Krueger; Francesco Martucci; Christoph Oehler; Mahmut Ozsahin; Alexandros Papachristofilou; Dirk Wagnetz; Kathrin Zaugg; Daniel Zwahlen; Isabelle Opitz; Paul Martin Putora
Journal:  Transl Lung Cancer Res       Date:  2021-04

3.  Questionnaire survey comparing surgery and stereotactic body radiotherapy for lung cancer: lessons from patients with experience of both modalities.

Authors:  Atsuya Takeda; Naoko Sanuki; Yuichiro Tsurugai; Masataka Taguri; Nobuyuki Horita; Yu Hara; Takahisa Eriguchi; Takeshi Akiba; Akitomo Sugawara; Etsuo Kunieda; Takeshi Kaneko
Journal:  J Thorac Dis       Date:  2019-06       Impact factor: 2.895

4.  Helping patients with lung cancer choose between surgery or stereotactic body radiotherapy: the importance of the patient experience.

Authors:  Michael MacManus; Richard De Abreu Lourenco; Fiona Hegi-Johnson
Journal:  J Thorac Dis       Date:  2019-11       Impact factor: 2.895

5.  International guidelines on stage III N2 nonsmall cell lung cancer: surgery or radiotherapy?

Authors:  Paul Martin Putora; Pawel Leskow; Fiona McDonald; Tim Batchelor; Matthiew Evison
Journal:  ERJ Open Res       Date:  2020-02-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.